Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombopoietin.

S Bolam1

  • 1Department of Haematology, Royal Bournemouth Hospital, UK.

Transfusion Science
|February 6, 1997
PubMed
Summary
This summary is machine-generated.

Thrombopoietin (TPO), the key factor for megakaryocyte growth, was cloned in 1994. This review details TPO

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An approach for the identification of exemplar sites for scaling up targeted field observations of benthic biogeochemistry in heterogeneous environments.

Biogeochemistry·2020
Same author

Response of intertidal macrofauna to multiple disturbance types and intensities - an experimental approach.

Marine environmental research·2010
Same author

Slide session, British Society for Haematology, 45th Annual Scientific Meeting, Manchester, 2005.

Clinical and laboratory haematology·2005
Same author

Peripheral blood CD34+ cell counts allow improved management of peripheral blood stem cell collections.

British journal of biomedical science·2004
Same author

The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen.

Cancer chemotherapy and pharmacology·2004
Same author

Colony-stimulating factors in the treatment of older patients with acute myelogenous leukaemia.

Drugs & aging·2000
Same journal

Discontinuous automated calcium supplementation during thrombocytapheresis with the haemonetics MCS+ version C.

Transfusion science·2002
Same journal

Is Brazil entering a new age?

Transfusion science·2001
Same journal

Is Brazil entering a new age?

Transfusion science·2001
Same journal

Post-transfusion thrombocytopenia in recipients with anti-HLA antibody.

Transfusion science·2000
Same journal

The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values.

Transfusion science·2000
Same journal

A relationship between glucose metabolism and NO-mediated iron mobilization from cells.

Transfusion science·2000
See all related articles

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Thrombopoietin (TPO) was identified as a major growth factor for megakaryocytes.
  • The TPO gene (c-mpl) encodes a receptor for a hematopoietic cytokine.
  • A viral oncogene (v-mpl) was previously linked to myeloproliferative disorders.

Purpose of the Study:

  • To review the structure and function of TPO.
  • To discuss the role of TPO in megakaryocyte proliferation and maturation.
  • To explore the clinical potential of TPO in hematologic oncology.

Main Methods:

  • Literature review of TPO structure, function, and clinical applications.
  • Analysis of TPO's role in megakaryopoiesis.
  • Evaluation of TPO's therapeutic potential.

Related Experiment Videos

Main Results:

  • TPO is the primary regulator of megakaryocyte development.
  • TPO stimulates both proliferation and maturation of megakaryocytes.
  • Pre-clinical data suggest TPO's efficacy as a platelet-sparing agent.

Conclusions:

  • TPO is crucial for platelet production and megakaryocyte development.
  • TPO holds significant promise for clinical use in hematologic oncology.
  • Further research is warranted to fully elucidate TPO's therapeutic applications.